시장보고서
상품코드
1267645

실험실 자동화 시장 : 자동화 단계별, 기기 유형별, 최종사용자별, 주요 지역별 : 업계 동향과 세계 예측(2023-2035년)

Lab Automation Market: Distribution by Stage of Automation, Type of Instrument, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

발행일: | 리서치사: Roots Analysis | 페이지 정보: 영문 231 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 실험실 자동화 시장 규모는 현재 52억 달러를 기록했습니다. 시장은 2023-2035년의 기간 중에 CAGR로 13%의 성장이 전망되며, 현저한 속도로 성장할 것으로 예측됩니다. 지역별로는 아시아태평양의 실험실 자동화 시장은 장기적으로 비교적 빠른 속도로 성장할 것으로 보입니다.

세계의 실험실 자동화 시장에 대해 조사했으며, 시장 개요와 함께 자동화 단계별, 기기 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 서론

제4장 시장 상황

  • 실험실 자동화 시스템 제조업체 : 전체적 시장 상황

제5장 기업 경쟁력 분석

  • 가정과 주요 파라미터
  • 조사 방법
  • 경쟁력 분석 : 북미에 거점을 두는 초소규모 기업
  • 경쟁력 분석 : 북미에 거점을 두는 소규모 기업
  • 경쟁력 분석 : 북미에 거점을 두는 중규모 기업
  • 경쟁력 분석 : 북미에 거점을 두는 대기업
  • 경쟁력 분석 : 북미에 거점을 두는 초대형 기업
  • 경쟁력 분석 : 유럽에 거점을 두는 초소규모 기업
  • 경쟁력 분석 : 유럽에 거점을 두는 소규모 기업
  • 경쟁력 분석 : 유럽에 거점을 두는 중규모 기업
  • 경쟁력 분석 : 유럽에 거점을 두는 대기업
  • 경쟁력 분석 : 아시아태평양에 거점을 두는 소규모 기업
  • 경쟁력 분석 : 아시아태평양 및 기타 지역에 거점을 두는 소규모 기업
  • 경쟁력 분석 : 아시아태평양 및 기타 지역에 거점을 두는 중규모 기업
  • 경쟁력 분석 : 아시아태평양 및 기타 지역에 거점을 두는 대기업
  • 경쟁력 분석 : 아시아태평양에 거점을 두는 초대형 기업

제6장 기업 개요

  • Abbott
  • Anton Paar
  • BD
  • Beckman Coulter
  • ERWEKA
  • Leuze
  • Ortho Clinical Diagnostics
  • Pall Corporation
  • PerkinElmer
  • Roche Diagnostics
  • Siemens Healthineers
  • SYSTAG

제7장 파트너십과 협업

  • 파트너십 모델
  • 실험실 자동화 : 파트너십과 협업 리스트

제8장 특허 분석

제9장 시장 예측과 기회 분석

  • 조사 방법과 주요 가정
  • 세계의 실험실 자동화 시장, 2023-2035년
  • 실험실 자동화 시장 : 최종사용자별, 2023-2035년
  • 실험실 자동화 시장 : 주요 지역별, 2023-2035년

제10장 사례 연구 : 실험실 자동화 소프트웨어

  • 실험실 자동화 소프트웨어 프로바이더 : 전체적 시장 상황

제11장 경영진 인사이트

제12장 부록 I : 표 형식 데이터

제13장 부록 II : 회사 및 조직 리스트

KSM 23.05.11

INTRODUCTION

Owing to the growing demand for complex biopharmaceuticals, the number of laboratories providing analytical and product development solutions has increased significantly across the globe. During each step of a laboratory process, it is essential to ensure that all the variables and parameters are under control. However, there are several challenges associated with conventional and manual handling, such as the high risk of sample contamination, high labor costs, time management, operator-to-operator variations and lack of real-time data availability. According to a research article published by Nature, over 70% of scientists were unable to replicate a previously published experiment. This has created a demand for instruments that can reduce the chances of errors, save time and money and boost reproducibility. As a result, lab automation has emerged as the most suitable alternative since it has the ability to overcome the issues associated with manual handling. By eliminating laborious and repetitive processes in the lab, automated technologies enable researchers to focus more on specialized operations. Additionally, lab automation minimizes the risk of human errors while maintaining data accuracy and traceability. We believe that the lab automation market will grow significantly in the coming years, owing to significant advancements and the fact that lab automation and related modules can be customized to meet individual needs.

SCOPE OF THE REPORT

The Lab Automation Market: Distribution by Stage of Automation (Pre-analytical Stage, Analytical Stage, Post-Analytical Stage and Total Lab Automation), Type of Instrument (Automated Liquid Handling Systems, Automated Microplate Readers, Automated Sampling Systems, Analyzers, Automated Storage and Retrieval Systems (ASRS) and Other Instruments), End-user (Pharmaceutical and Biotechnology Companies, Research and Diagnostic Laboratories and Other End-Users) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. The report answers many key questions related to this domain.

Benefits and Growing Demand for Lab Automation

Lab automation refers to the use of any equipment or device that may execute tasks in the lab with little or no hands-on engagement from professionals. It is one of the rapidly emerging concepts that involves integration of automated technologies into laboratories to enhance operations, including pipetting and data analysis, involved in various day-to-day laboratory practices. Lab automation devices, such as automated liquid handling systems have several advantages, including the ability to simplify sample preparation while maintaining consistent high accuracy and allowing labs to free up manual labor and run more samples along with maintaining reproducibility. Further, automated storage and retrieval systems (ASRS) lower down the variable cost of operations by eliminating the need for manual labor for tasks such as picking, storing, assembly and inventory replenishment. This increases the level of accountability and security preventing inventory shrinkage and allowing to locate missing or misplaced items. It is worth highlighting that large-scale automation employing robotic workstations is generally used in clinical, pharmaceutical and life science labs, where a large number of tests and studies are conducted on a daily basis.

Current Market Landscape of the Lab Automation System Manufacturers

The lab automation market is among the most promising domains in the healthcare industry. Currently, around 350 companies have the required capabilities to manufacture lab automation system. Notably, at present, around 50% of these lab automation system manufacturers are focusing on automated liquid handling systems, as it reduces the chances of human error in the pre-analytical stage of diagnostics, where most of the error occurs.

Automated Storage and Retrieval Systems (ASRS)

The use of automated storage and retrieval systems (ASRS) allows an operator to have better inventory control. In the case of manual inventory control, an operator must check the inventory on a regular basis to obtain pertinent information. Automated storage and retrieval systems (ASRS) keep the inventory safe, secure and under control by enclosing it in a fully enclosed system. This assist to track missing or misplaced goods which increases level of accountability and security preventing inventory shrinkage.

Partnership and Collaboration Trends in the Lab Automation Domain

In recent years, several partnerships have been inked by various stakeholders in order to consolidate their presence in this field and enhance their capabilities and product portfolio to meet the growing demand for lab automation systems. Acquisitions, product development agreements and distribution agreements are the most common types of partnerships inked by stakeholders in the lab automation domain. Further, majority of such partnerships are focused on various automation instruments, including automated data analysis, automated liquid handling systems and total lab automation.

Key Trends in the Lab Automation Market

Over 6,200 patents focused on lab automation have been granted / filed in the past six years, indicating the substantial efforts made by researchers engaged in this domain. Primarily, most of the patents have been filed to advance research on various components of lab automation systems, such as samples, labels, devices and tests.

Market Size of the Lab Automation Market

Driven by enhanced productivity and improved timelines, lucrative opportunities are expected to emerge for players developing lab automation systems. The global lab automation market is anticipated to grow at a significant pace, with a CAGR of 13% during the period 2023-2035. Among the stages of automation, the pre-analytical stage is most likely to adopt lab automation because it has the highest risk of error during laboratory diagnostics. in terms of geography, the lab automation market in Asia-Pacific is likely to grow at a relatively faster pace in the long term.

Automated Liquid Handling Systems will Continue to Dominate the Market

Automated liquid handling systems are anticipated to capture the largest share of the market. Liquid handling systems have seen increased adoption in not only the pharma and biotech laboratories, but also academic laboratories. With this, automated liquid handling technology is constantly improving and players are integrating the advanced features. Recently, Microlab STAR Liquid Handling System by Hamilton has been awarded as 2022 Good Design Award by The Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies. In this new automated liquid handling system, Hamilton integrates innovative functions, flexibility, and ease of use in a minimalistic and transparent appearance.

Key Players in the Lab Automation Market

Examples of the key players in this domain (the complete list of players is available in the full report) include (in alphabetic order) Abbott, Anton Paar, BD, Beckman Coulter, ERWEKA, Leuze, Ortho Clinical Diagnostics, Pall Corporation, PerkinElmer, Roche Diagnostics, Siemens Healthineers and SYSTAG.

Amongst other elements, the report includes:

  • An executive summary of the insights captured during our research, offering a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.
  • A general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.
  • A detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplate systems (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).
  • A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation system being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).
  • Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
  • An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
  • A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories).

One of the key objectives of the report was to evaluate the current opportunity and future growth potential associated with the lab automation market, over the coming years. We have provided informed estimates on the likely evolution of the market in the mid-to-long term for the period 2023-2035. Our year-wise projections of the current and future opportunity have been further segmented based on relevant parameters, such as stage of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), type of instrument (automated liquid handling systems, automated microplate readers, automated sampling systems, analyzers, automated storage and retrieval systems (ASRS) and other instruments), end-user (pharmaceutical and biotechnology companies, research and diagnostic laboratories and other end-users) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's evolution.

The opinions and insights presented in the report were influenced by discussions held with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

  • Barcella Mauro (Chief Executive Officer, A.S.T. Biomedical)
  • Shai Kaplan (Co-Founder and Co-Chief Executive Officer, SciRobotics)
  • Patrick Widler (Chief Commercial Officer, HSE)
  • Dimitris Kyriakou (Project Manager and Business Development, Efevre Tech)
  • Abiodun Sina-Olulana (Production and Supply Management Lead, Africa Medical Supplies Platform)
  • Daniel von Sierakowski (Account Manager, Inheco)
  • Mayookh Sengupta (Sales Manager, LabWare)
  • Anonymous (Berthold Technologies)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via primary and secondary research. For all our projects, we conduct interviews / surveys with reputed domain experts (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Question 1: What is lab automation?

Answer: Lab automation refers to the use of any lab instrument, equipped with the required software that executes tasks in the lab with little or no hands-on engagement from professionals. Automation can be used anywhere, from a single step of an experimental process to the entire workflow.

Question 2: What is automated liquid handling system? What are examples of liquid handling systems?

Answer: Automated liquid handling systems are devices used for dispensing and sampling liquids in tubes or wells. Owing to the capability to dispense liquid volumes up to nanoliters with great precision and accuracy, there has been an increased demand for such systems in research laboratories, universities and the clinical research industry. Some examples of automated liquid handling systems include (in alphabetical order) Echo® 650 (Beckman Coulter), epMotion® (Eppendorf), Microlab® STAR™ (Hamilton) and Tecan Freedom Evo® (Tecan).

Question 3: How many players are currently involved in the development of lab automation systems?

Answer: Presently, around 350 companies are developing various lab automation devices, including automated liquid handling systems, automated microplates, automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation systems.

Question 4: Which are the top players in the lab automation market?

Answer: Examples of top players engaged in this domain (which have also been captured in this report) include (in alphabetical order) include Abbott, Anton Paar, BD, Beckman Coulter, ERWEKA, Leuze, Ortho Clinical Diagnostics, Pall Corporation, PerkinElmer, Roche Diagnostics, Siemens Healthineers and SYSTAG.

Question 5: What is the global market size of the lab automation market?

Answer: The current global lab automation market size is estimated to be USD 5.2 Billion.

Question 6: What is the growth rate of lab automation market?

Answer: The global lab automation market is expected to grow at an annualized rate of 13% during the period 2023-2035.

Question 7: Which region is likely to hold the largest share in the lab automation market?

Answer: Currently, North America is anticipated to capture the largest market share (38%). In addition, the market in Asia-Pacific is likely to grow at a relatively faster pace in the long term.

Question 8: What is the market share of automated liquid handling systems?

Answer: Automated liquid handling systems are anticipated to capture over 30% of the market share by 2035 and this trend is unlikely to change during the forecasted period.

Question 9: What are the factors driving the lab automation market?

Answer: Automation generates high-quality data, provides better documentation and enables the various end-users to generate more data with less effort. As a result, increased reproducibility and precision are projected to drive the growth of the lab automation market.

CHAPTER OUTLINES

  • Chapter 1 provides an introduction to the scope of Lab Automation Market, 2023-2035 report.
  • Chapter 2 provides an executive summary of the key insights captured in our report. It offers a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.
  • Chapter 3 provides a general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.
  • Chapter 4 includes detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplates (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).
  • Chapter 5 provides an insightful company competitiveness analysis of lab automation manufacturers based on various relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation systems being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).
  • Chapter 6 includes elaborate profiles of the key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • Chapter 7 provides detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
  • Chapter 8 features an in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
  • Chapter 9 provides an insightful market forecast and opportunity analysis, highlighting the future growth potential of lab automation market till the year 2035. In order to provide details on the future opportunity, our projections have been segmented based on stage of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), type of instrument (automated liquid handling systems, automated microplates, automated sampling systems, automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), end-user (pharmaceutical and biotechnology companies, research and diagnostic laboratories, and other end-users) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).
  • Chapter 10 presents a case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories).
  • Chapter 11 provides the transcripts of the interviews conducted with key stakeholders in this industry. The chapter presents the details of our conversation with Barcella Mauro (Chief Executive Officer, A.S.T. Biomedical), Shai Kaplan (Co-Founder and Co-Chief Executive Officer, SciRobotics), Patrick Widler (Chief Commercial Officer, HSE), Dimitris Kyriakou (Project Manager and Business Development, Efevre Tech), Abiodun Sina-Olulana (Production and Supply Management Lead, Africa Medical Supplies Platform), Daniel von Sierakowski (Account Manager, Inheco), Mayookh Sengupta (Sales Manager, LabWare) and Anonymous (Berthold Technologies).
  • Chapter 12 is an appendix, which contains tabulated data and numbers for all the figures included in the report.
  • Chapter 13 is an appendix, which contains the list of companies and organizations mentioned in the report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Overview of Lab Automation
  • 3.2. Historical Evolution of Lab Automation
  • 3.3. Stages of Lab Automation
  • 3.4. Process of Lab Automation
  • 3.5. Advantages of Lab Automation Over Manual Handling
  • 3.6. Challenges associated with Lab Automation
  • 3.7. Future Perspectives

4. MARKET LANDSCAPE

  • 4.1. Lab Automation System Manufacturers: Overall Market Landscape
    • 4.1.1. Analysis by Year of Establishment
    • 4.1.2. Analysis by Company Size
    • 4.1.3. Analysis by Location of Headquarters
    • 4.1.4. Analysis by Company Size and Location of Headquarters
    • 4.1.5. Analysis by Type of Lab Automation System(s)
    • 4.1.6. Analysis by Type of Automated Liquid Handler(s)
    • 4.1.7. Analysis by Type of Automated Microplate(s)
    • 4.1.8. Analysis by Stage(s) of Automation
    • 4.1.9. Analysis by Application Area(s)
    • 4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s)
    • 4.1.11. Analysis by End-user(s)
    • 4.1.12. Analysis by Stage(s) of Automation and End-user(s)

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Assumptions and Key Parameters
  • 5.2 Methodology
  • 5.3. Competitiveness Analysis: Very Small Companies based in North America

(Peer Group I)

  • 5.4. Competitiveness Analysis: Small Companies based in North America (Peer

Group II)

  • 5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
  • 5.5. Competitiveness Analysis: Large Companies based in North America (Peer

Group IV)

  • 5.6. Competitiveness Analysis: Very Large Companies based in North America

(Peer Group V)

  • 5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group

VI)

  • 5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
  • 5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group

VII)

  • 5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
  • 5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group

X)

  • 5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and

Rest of the World (Peer Group XI)

  • 5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of

the World (Peer Group XII)

  • 5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest

of the World (Peer Group XIII)

  • 5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of

the World (Peer Group XIV)

  • 5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and

Rest of the World (Peer Group XV)

6. COMPANY PROFILES

  • 6.1. Abbott
    • 6.1.1. Company Overview
    • 6.1.2. Financial Information
    • 6.1.3. Lab Automation Product Portfolio
    • 6.1.4. Recent Developments and Future Outlook
  • 6.2. Anton Paar
    • 6.2.1. Company Overview
    • 6.2.2. Financial Information
    • 6.2.3. Lab Automation Product Portfolio
    • 6.2.4. Recent Developments and Future Outlook
  • 6.3. BD
    • 6.3.1. Company Overview
    • 6.3.2. Financial Information
    • 6.3.3. Lab Automation Product Portfolio
    • 6.3.4. Recent Developments and Future Outlook
  • 6.4. Beckman Coulter
    • 6.4.1. Company Overview
    • 6.4.2. Financial Information
    • 6.4.3. Lab Automation Product Portfolio
    • 6.4.4. Recent Developments and Future Outlook
  • 6.5. ERWEKA
    • 6.5.1. Company Overview
    • 6.5.2. Financial Information
    • 6.5.3. Lab Automation Product Portfolio
    • 6.5.4. Recent Developments and Future Outlook
  • 6.6. Leuze
    • 6.6.1. Company Overview
    • 6.6.2. Financial Information
    • 6.6.3. Lab Automation Product Portfolio
    • 6.6.4. Recent Developments and Future Outlook
  • 6.7. Ortho Clinical Diagnostics
    • 6.7.1. Company Overview
    • 6.7.2. Financial Information
    • 6.7.3. Lab Automation Product Portfolio
    • 6.7.4. Recent Developments and Future Outlook
  • 6.8. Pall Corporation
    • 6.8.1. Company Overview
    • 6.8.2. Financial Information
    • 6.8.3. Lab Automation Product Portfolio
    • 6.8.4. Recent Developments and Future Outlook
  • 6.9. PerkinElmer
    • 6.9.1. Company Overview
    • 6.9.2. Financial Information
    • 6.9.3. Lab Automation Product Portfolio
    • 6.9.4. Recent Developments and Future Outlook
  • 6.10. Roche Diagnostics
    • 6.10.1. Company Overview
    • 6.10.2. Financial Information
    • 6.10.3. Lab Automation Product Portfolio
    • 6.10.4. Recent Developments and Future Outlook
  • 6.11. Siemens Healthineers
    • 6.11.1. Company Overview
    • 6.11.2. Financial Information
    • 6.11.3. Lab Automation Product Portfolio
    • 6.11.4. Recent Developments and Future Outlook
  • 6.12. SYSTAG
    • 6.12.1. Company Overview
    • 6.12.2. Financial Information
    • 6.12.3. Lab Automation Product Portfolio
    • 6.12.4. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS

  • 7.1. Partnership Models
  • 7.2. Lab Automation: List of Partnerships and Collaborations
    • 7.2.1. Analysis by Year of Partnership
    • 7.2.2. Analysis by Type of Partnership
    • 7.2.3. Analysis by Year and Type of Partnership
    • 7.2.4. Analysis by Type of Partner
    • 7.2.5. Analysis by Year of Partnership and Type of Partner
    • 7.2.6. Analysis by Type of Partnership and Type of Partner
    • 7.2.7. Analysis by Type of Automation Instrument(s)
    • 7.2.8. Analysis by Type of Partnership and Automation Instrument(s)
    • 7.2.9. Most Active Players: Analysis by Number of Partnerships
    • 7.2.10. Analysis by Geography
      • 7.2.10.1. Local and International Agreements
      • 7.2.10.2. Intracontinental and Intercontinental Agreements

8. PATENT ANALYSIS

  • 8.1. Methodology and Key Parameters
  • 8.2. Lab Automation: List of Patents
  • 8.3. Analysis by Patent Publication Year
  • 8.4. Analysis by Publication Year and Type of Patent
  • 8.5. Analysis by Application Year
  • 8.6. Analysis by Patent Jurisdiction
  • 8.7. Analysis by CPC Symbols
  • 8.8. Analysis by Type of Applicant
  • 8.9. Word Cloud: Emerging Focus Areas
  • 8.10. Analysis by Patent Age
  • 8.11. Leading Industry Players: Analysis by Number of Patents
  • 8.12. Leading Non-Industry Players: Analysis by Number of Patents
  • 8.13. Leading Individual Assignees: Analysis by Number of Patents
  • 8.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent

Characterization (CPC Symbols)

  • 8.15. Patent Valuation: Methodology and Key Parameters
    • 8.15.1. Analysis by Relative Patent Valuation

9. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 9.1. Methodology and Key Assumptions
  • 9.2. Global Lab Automation Market, 2023-2035
    • 9.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
      • 9.2.1.1. Lab Automation Market for Pre-analytical Stage, 2023-2035
      • 9.2.1.2. Lab Automation Market for Analytical Stage, 2023-2035
      • 9.2.1.3. Lab Automation Market for Post-analytical Stage, 2023-2035
      • 9.2.1.4. Lab Automation Market for Total Lab Automation, 2023-2035
    • 9.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
      • 9.2.2.1. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035
      • 9.2.2.2. Lab Automation Market for Automated Microplate Readers, 2023-2035
      • 9.2.2.3. Lab Automation Market for Automated Sampling Systems, 2023-2035
      • 9.2.2.4. Lab Automation Market for Analyzers, 2023-2035
      • 9.2.2.5. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS),

2023-2035

      • 9.2.2.6. Lab Automation Market for Other Instruments, 2023-2035
    • 9.2.3. Lab Automation Market: Distribution by End-user, 2023 and 2035
      • 9.2.3.1. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035
      • 9.2.3.2. Lab Automation Market for Biotechnology and Pharmaceutical Industries,

2023-2035

      • 9.2.3.3. Lab Automation Market for Other End-users, 2023-2035
    • 9.2.4. Lab Automation Market: Distribution by Key Geographical Regions, 2023 and

2035

      • 9.2.4.1. Lab Automation Market in North America, 2023-2035
      • 9.2.4.2. Lab Automation Market in Europe, 2023-2035
      • 9.2.4.3. Lab Automation Market in Asia-Pacific, 2023-2035
      • 9.2.4.4. Lab Automation Market in Middle East and North Africa, 2023-2035
      • 9.2.4.5. Lab Automation Market in Latin America, 2023-2035

10. CASE STUDY: LAB AUTOMATION SOFTWARE

  • 10.1. Lab Automation Software Providers: Overall Market Landscape
    • 10.1.1. Analysis by Year of Establishment
    • 10.1.2. Analysis by Company Size
    • 10.1.3. Analysis by Location of Headquarters
    • 10.1.4. Analysis by Company Size and Location of Headquarters
    • 10.1.5. Analysis by Type of Software
    • 10.1.6. Analysis by Mode(s) of Deployment
    • 10.1.7. Analysis by Type of Software and Mode(s) of Deployment
    • 10.1.8. Analysis by End-user(s)
    • 10.1.9. Analysis by Type of Software and End-user(s)

11. EXECUTIVE INSIGHTS

  • 11.1. Chapter Overview
  • 11.2. Africa Medical Supplies Platform
    • 11.2.1. Company Overview
    • 11.2.2. Interview Transcript: Abiodun Sina-Olulana (Production and Supply

Management Lead)

  • 11.3. A.S.T. Biomedical
    • 11.3.1. Company Overview
    • 11.3.2. Interview Transcript: Barcella Mauro (Chief Executive Officer)
  • 11.4. Berthold Technologies
    • 11.4.1. Company Overview
    • 11.4.2. Interview Transcript: Anonymous
  • 11.5. Efevre Tech
    • 11.5.1. Company Overview
    • 11.5.2. Interview Transcript: Dimitris Kyriakou (Project Manager and Business

Development)

  • 11.6. HSE
    • 11.6.1. Company Overview
    • 11.6.2. Interview Transcript: Patrick Widler (Chief Commercial Officer)
  • 11.7. Inheco
    • 11.7.1. Company Overview
    • 11.7.2. Interview Transcript: Daniel von Sierakowski (Account Manager)
  • 11.8. LabWare
    • 11.8.1. Company Overview
    • 11.8.2. Interview Transcript: Mayookh Sengupta (Sales Manager)
  • 11.9. SciRobotics
    • 11.9.1. Company Overview
    • 11.9.2. Interview Transcript: Shai Kaplan (Co-Founder and Co-Chief Executive

Officer)

12. APPENDIX I: TABULATED DATA

13. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제